Patents by Inventor Vladimir Jankovic

Vladimir Jankovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210008109
    Abstract: Provided herein are methods of treating a hematological disorder, a solid tumor, or an infectious disease in a subject in need thereof using natural killer cells in combination with a second agent, or using natural killer cells with genetic modifications for target specificity and/or homing specificity.
    Type: Application
    Filed: February 18, 2020
    Publication date: January 14, 2021
    Applicant: CELGENE CORPORATION
    Inventors: Lin KANG, Xiaokui ZHANG, Jeffrey HARRIS, Vladimir JANKOVIC
  • Publication number: 20180346877
    Abstract: Provided herein are methods of producing natural killer (NK) cells and/or ILC3 cells using a three-stage expansion and differentiation method with media comprising stem cell mobilizing factors. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells and/or ILC3 cells and the NK cell and/or ILC3 cell populations produced by the three-stage methods described herein to an individual having the cancer or viral infection.
    Type: Application
    Filed: October 14, 2016
    Publication date: December 6, 2018
    Applicant: CELULARITY, INC.
    Inventors: Xiaokui ZHANG, Ivana DJURETIC, Lin KANG, Vanessa VOSKINARIAN-BERSE, Bhavani STOUT, Robert J. HARIRI, Wolfgang HOFGARTNER, James EDINGER, Eric LAW, Vladimir JANKOVIC
  • Publication number: 20180071343
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 15, 2018
    Applicant: Celularity, Inc.
    Inventors: Stewart Abbot, James Edinger, Aleksander Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
  • Publication number: 20180021378
    Abstract: Provided herein are methods of treating a hematological disorder, a solid tumor, or an infectious disease in a subject in need thereof using natural killer cells in combination with a second agent, or using natural killer cells with genetic modifications for target specificity and/or homing specificity.
    Type: Application
    Filed: December 30, 2015
    Publication date: January 25, 2018
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Lin KANG, Xiaokui ZHANG, Jeffrey HARRIS, Vladimir JANKOVIC
  • Publication number: 20170290861
    Abstract: Provided herein are methods of using tissue culture plastic-adherent placental cells, e.g. placental stem cells, in the treatment of diabetic foot ulcer (DFU).
    Type: Application
    Filed: September 25, 2015
    Publication date: October 12, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Steven A. FISCHKOFF, Denesh CHITKARA, Uri HERZBERG, Vladimir JANKOVIC
  • Publication number: 20170252379
    Abstract: Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same. In one aspect, provided herein are compositions comprising exosomes produced by and/or derived from placental cells, e.g., placenta-derived adherent cells. In certain embodiments, the exosomes provided herein are produced by placenta-derived adherent cells that have been cultured in vitro for, e.g., 1, 2, 3, 4, 5, 6 or more passages.
    Type: Application
    Filed: October 8, 2015
    Publication date: September 7, 2017
    Applicant: Anthrogenesis Corporation
    Inventors: Eric LAW, Andrew MORSCHAUSER, Aleksandar FRANCKI, Jennifer PAREDES, Kathy E. KARASIEWICZ-MENDEZ, Allan REDUTA, Vladimir JANKOVIC, Ivana DJURETIC
  • Publication number: 20160361366
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Application
    Filed: October 22, 2015
    Publication date: December 15, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
  • Publication number: 20160106784
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Patent number: 9254302
    Abstract: Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: February 9, 2016
    Assignee: ANTHROGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Robert J. Hariri, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Patent number: 9198938
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: December 1, 2015
    Assignee: ANTRHOGENESIS CORPORATION
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav Padliya, Jennifer Paredes, Jia-Lun Wang
  • Publication number: 20150225697
    Abstract: Provided herein are methods of producing natural killer (NK) cells and NK progenitor cell populations using a two-step expansion and differentiation method. Also provided herein are methods of producing populations of NK cells and NK progenitor cell populations using a three-step expansion and differentiation method. Also provided herein are methods of suppressing tumor cell proliferation using the NK cells, the NK cell populations, and the NK progenitor cell populations produced by the methods described herein, as well as methods of treating individuals having cancer or a viral infection, comprising administering the NK cells, the NK cell populations, and the NK progenitor cell populations produced by the methods described herein to an individual having the cancer or viral infection.
    Type: Application
    Filed: August 13, 2013
    Publication date: August 13, 2015
    Applicant: Anthrogenesis Corporation
    Inventors: Eric Law, Lin Kang, Vladimir Jankovic, Xiaokui Zhang, Stewart Abbot, Robert J. Hariri
  • Publication number: 20150023926
    Abstract: Provided herein are methods of treating individuals having suffered exposure to radiation, e.g., individuals having radiation injury, by administering to the individuals angiogenic cells from amnion, referred to as amnion derived adherent cells, or populations of and compositions comprising, such cells.
    Type: Application
    Filed: July 13, 2012
    Publication date: January 22, 2015
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: Aleksandar Francki, Ajai Pal, Robert J. Hariri, Vladimir Jankovic
  • Publication number: 20140219970
    Abstract: Provided herein are compositions and methods of treating individuals having sarcoidosis or a sarcoidosis-related disease or disorder, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein. Also provided herein are kits comprising said cells or a composition thereof.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 7, 2014
    Applicant: Anthrogenesis Corporation
    Inventors: James W. Edinger, Steven Alan Fischkoff, Aleksandar Francki, Vladimir Jankovic, Bitao Liang, Philippe Martin, Cynthia Ray, Xiaockui Zhang
  • Publication number: 20140072538
    Abstract: Provided herein are methods of treating individuals having suffered exposure to radiation, e.g., individuals having radiation injury, by administering to the individuals angiogenic cells from amnion, referred to as amnion derived adherent cells, or populations of, and compositions comprising, such cells.
    Type: Application
    Filed: July 12, 2013
    Publication date: March 13, 2014
    Inventors: Aleksandar Francki, Ajai Pal, Robert J. Hariri, Vladimir Jankovic
  • Patent number: 8562973
    Abstract: Methods of treating individuals having sarcoidosis or a sarcoidosis-related disease or disorder using placental cells are described. Also describe are kits comprising placental stem cells or a composition thereof that can be used in methods of treating sarcoidosis or a sarcoidosis-related disease or disorder.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: October 22, 2013
    Assignee: Anthrogenesis Corporation
    Inventors: James W. Edinger, Steven Alan Fischkoff, Aleksandar Francki, Vladimir Jankovic, Bitao Liang, Philippe Martin, Cynthia Ray, Xiaokui Zhang
  • Patent number: 8367409
    Abstract: Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: February 5, 2013
    Assignee: Anthrogenesis Corporation
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Aleksandr Kaplunovsky, Vladimir Jankovic, Kristen Labazzo, Eric Law, Neerav D. Padliya, Jennifer Paredes, Jia-Lun Wang
  • Publication number: 20120201787
    Abstract: Provided herein are methods of treating spinal cord and traumatic brain injuries using cells from amnion, and populations of such cells, referred to herein as “amnion derived adherent cells” (“AMDACs”).
    Type: Application
    Filed: December 15, 2011
    Publication date: August 9, 2012
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Bitao Liang
  • Publication number: 20120164114
    Abstract: Provided herein are methods of using amnion derived adherent cells, and populations of, and compositions comprising, such cells, in the modulation of an immune response. In various embodiments, the immune response is graft-versus-host disease, an allergy, asthma, or an immune-related disease or disorder, e.g., an autoimmune disease.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 28, 2012
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Vladimir Jankovic, Bitao Liang
  • Publication number: 20120156230
    Abstract: Provided herein are methods of treatment of individuals having an injury to the central nervous system, such as a spinal cord injury or a traumatic brain injury, using placental stem cells and placental multipotent stem cells described herein, and populations of such placental cells.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 21, 2012
    Inventors: Stewart Abbot, James W. Edinger, Aleksandar Francki, Vladimir Jankovic, Aleksandr Kaplunovsky, Kristen Labazzo, Eric Law, Bitao Liang
  • Publication number: 20110311491
    Abstract: Provided herein are compositions and methods of treating individuals having sarcoidosis or a sarcoidosis-related disease or disorder, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein. Also provided herein are kits comprising said cells or a composition thereof.
    Type: Application
    Filed: April 6, 2011
    Publication date: December 22, 2011
    Applicant: ANTHROGENESIS CORPORATION
    Inventors: James W. EDINGER, Steven Alan FISCHKOFF, Aleksander FRANCKI, Vladimir JANKOVIC, Bitao LIANG, Philippe MARTIN, Cynthia RAY, Xiaokui ZHANG